Artificial Intelligence

Kezar Life Sciences faces a critical FDA meeting for its novel liver disease drug, a decision that could bring hope to patients and define the company's future.

Laser tool maker Huepar validates its 5-year warranty with automated precision and plans a major service expansion in the UK, Europe, and the US.

Amid a major corporate restructure, Atos partners with the World DanceSport Federation, betting on tech to transform the ballroom and secure its market lead.

A 2.9 MEUR deal for GomSpace to design lunar spacecraft for a major North American firm signals a new era for small satellites in deep space exploration.

Global Capability Centers are shedding their cost-center image, embracing AI-first models and expanding into new Indian cities to become strategic innovators.

The semiconductor giant's stellar revenue, driven by a 19% surge in its core packaging business, confirms strong demand for AI and advanced tech.

A new AI-designed vaccine, TG4050, has prevented relapse in all head and neck cancer patients in a key trial, signaling a breakthrough in personalized medicine.

A major pharma giant is betting on artificial intelligence to accelerate cancer drug discovery, a move that could reshape the future of oncology treatment.

At CES 2026, an awards ceremony marks two decades of upheaval, chronicling China's rise from follower to leader in the global electronics industry.

Belgian biotech MRM Health gets the green light for a Phase 2b trial of MH002, a novel 'living drug' aimed at revolutionizing ulcerative colitis care.

Making its CES debut, Chinese supplier InfiMotion unveiled next-gen electric drives that promise more power and efficiency in a lighter, integrated package.

Swiss lab automation giant Tecan shows signs of a turnaround with robust H2 2025 orders, betting on AI to navigate a recovering life sciences market.

As Valneva meets investors, all eyes are on its pivotal Lyme disease vaccine data, a potential game-changer for public health and the company's future.

A new report reveals shifting consumer demands for THCA flower, as the booming market grapples with quality standards and a complex regulatory future.

FieldBee Vision's gold medal win at LAMMA 2026 signals a new era of accessible, AI-driven precision agriculture for farms of all sizes.

Dr. Jill Tarter, the real-life inspiration for 'Contact,' wins the Green Sands Prize, validating her decades-long quest to legitimize the search for E.T.

A key regulatory shift enables US-based Monnit to partner with Widetec, aiming to solve Japan's labor and infrastructure challenges with IoT solutions.

The global VR leader continues its rapid Canadian growth, opening a high-tech virtual reality venue in Vaughan amid a booming market for immersive group fun.

With a new CEO from Illumina and Exact Sciences, Quanterix signals a strategic shift from tech development to aggressive market and clinical expansion.

From firefighting robots to AI health diagnostics, Hong Kong's record delegation at CES 2026 wins big, signaling its arrival as a global tech powerhouse.